16,179 Novanta Inc. $NOVT Shares Sold by William Blair Investment Management LLC

William Blair Investment Management LLC lessened its holdings in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 2.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 749,688 shares of the technology company’s stock after selling 16,179 shares during the period. William Blair Investment Management LLC owned approximately 1.98% of Novanta worth $106,598,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. State Street Corp lifted its position in shares of Novanta by 7.3% during the 2nd quarter. State Street Corp now owns 1,436,785 shares of the technology company’s stock valued at $233,005,000 after acquiring an additional 97,621 shares during the period. Tidal Investments LLC boosted its stake in shares of Novanta by 615.8% during the 2nd quarter. Tidal Investments LLC now owns 34,631 shares of the technology company’s stock worth $5,619,000 after acquiring an additional 29,793 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of Novanta by 18.3% during the 1st quarter. Bank of America Corp DE now owns 456,241 shares of the technology company’s stock worth $53,887,000 after acquiring an additional 70,728 shares in the last quarter. Oppenheimer Asset Management Inc. purchased a new stake in shares of Novanta during the 2nd quarter worth approximately $5,797,000. Finally, Wellington Management Group LLP grew its holdings in shares of Novanta by 10.5% in the 2nd quarter. Wellington Management Group LLP now owns 460,896 shares of the technology company’s stock worth $74,776,000 after acquiring an additional 43,659 shares during the period. Hedge funds and other institutional investors own 98.35% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on NOVT. Zacks Research downgraded Novanta from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Robert W. Baird reduced their price objective on Novanta from $194.00 to $175.00 and set an “outperform” rating for the company in a report on Thursday. Weiss Ratings downgraded Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, November 10th. Finally, Wall Street Zen lowered Novanta from a “buy” rating to a “hold” rating in a report on Sunday. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $175.00.

Get Our Latest Stock Report on NOVT

Novanta Stock Performance

Shares of Novanta stock opened at $118.88 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.18 and a quick ratio of 0.76. The business has a 50 day moving average price of $140.29 and a 200 day moving average price of $142.25. The company has a market capitalization of $4.50 billion, a P/E ratio of 90.75, a P/E/G ratio of 2.58 and a beta of 1.71. Novanta Inc. has a 1 year low of $98.27 and a 1 year high of $176.38.

Novanta (NASDAQ:NOVT – Get Free Report) last released its quarterly earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.08. Novanta had a return on equity of 10.23% and a net margin of 4.89%. The company had revenue of $305.01 million during the quarter, compared to analysts’ expectations of $301.02 million. During the same period in the previous year, the firm posted $0.87 earnings per share. The business’s revenue for the quarter was up 23.1% compared to the same quarter last year. Sell-side analysts anticipate that Novanta Inc. will post 3.68 EPS for the current fiscal year.

Novanta Company Profile

(Free Report)

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

Featured Stories

Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.